Vanguard Group Inc Vir Biotechnology, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 13,130,635 shares of VIR stock, worth $129 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,130,635

Previous 13,135,956 0.04%

Holding current value

$129 Million

Previous $98.4 Million 2.04%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$6.74 - $10.17 $35,863 - $54,114	-5,321 Reduced 0.04%	13,130,635 $96.4 Million
Q3 2024 Nov 13, 2024	BUY	$7.26 - $10.7 $2.08 Million - $3.07 Million	286,739 Added 2.23%	13,135,956 $98.4 Million
Q2 2024 Aug 13, 2024	BUY	$7.63 - $12.66 $3.62 Million - $6 Million	473,862 Added 3.83%	12,849,217 $114 Million
Q1 2024 May 10, 2024	BUY	$8.6 - $11.9 $672,657 - $930,770	78,216 Added 0.64%	12,375,355 $125 Million
Q4 2023 Feb 14, 2024	BUY	$7.76 - $10.29 $8.51 Million - $11.3 Million	1,096,473 Added 9.79%	12,297,139 $124 Million
Q3 2023 Nov 14, 2023	BUY	$9.14 - $24.62 $8.78 Million - $23.6 Million	960,302 Added 9.38%	11,200,666 $105 Million
Q2 2023 Aug 14, 2023	SELL	$23.2 - $27.29 $628,673 - $739,504	-27,098 Reduced 0.26%	10,240,364 $251 Million
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $3.85 Million - $5.34 Million	172,961 Added 1.71%	10,267,462 $239 Million
Q4 2022 Feb 10, 2023	BUY	$19.96 - $28.22 $3.32 Million - $4.69 Million	166,085 Added 1.67%	10,094,501 $255 Million
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $31.6 Million - $53.8 Million	1,731,172 Added 21.12%	9,928,416 $191 Million
Q2 2022 Aug 12, 2022	BUY	$19.08 - $26.7 $8.37 Million - $11.7 Million	438,847 Added 5.66%	8,197,244 $209 Million
Q1 2022 May 13, 2022	BUY	$21.19 - $40.01 $9.07 Million - $17.1 Million	428,266 Added 5.84%	7,758,397 $200 Million
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $3.4 Million - $5.93 Million	109,814 Added 1.52%	7,330,131 $307 Million
Q3 2021 Nov 12, 2021	BUY	$34.9 - $54.54 $33.4 Million - $52.3 Million	958,060 Added 15.3%	7,220,317 $314 Million
Q2 2021 Aug 13, 2021	BUY	$38.75 - $51.0 $243 Million - $319 Million	6,262,257 New	6,262,257 $296 Million

Others Institutions Holding VIR

# of Institutions

231

Shares Held

90.1M

Call Options Held

1.28M

Put Options Held

235K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.3B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Vir Biotechnology, Inc. Transaction History